DTIL · Categories · Form 4

DTIL - SEC Form 4 insider transactions

Precision BioSciences Inc. (DTIL) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for DTIL

• 4d
  SEC Form 4 filed by Director Brown Melinda

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 4d
  SEC Form 4 filed by Director Frankel Stanley

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 4d
  SEC Form 4 filed by Director Germano Geno J

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 4d
  SEC Form 4 filed by Director Pire Shari Lisa

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 4d
  SEC Form 4 filed by Director Buehler Kevin

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 5d
  SEC Form 4 filed by Chief Research Officer Smith J. Jefferson

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 5d
  SEC Form 4 filed by Chief Financial Officer Kelly John Alexander

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 5d
  SEC Form 4 filed by General Counsel and Secretary Scimeca Dario

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 5d
  SEC Form 4 filed by President and CEO Amoroso Michael

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 18d
  Director Buehler Kevin converted options into 21,000 shares, increasing direct ownership by 75% to 49,137 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 18d
  Director Frankel Stanley converted options into 21,000 shares, increasing direct ownership by 108% to 40,478 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 18d
  Director Brown Melinda converted options into 21,000 shares, increasing direct ownership by 90% to 44,346 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 18d
  Director Pire Shari Lisa converted options into 21,000 shares, increasing direct ownership by 150% to 35,028 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 18d
  Director Germano Geno J converted options into 21,000 shares, increasing direct ownership by 88% to 44,883 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 109d
  President and CEO Amoroso Michael converted options into 67,797 shares and sold $78,947 worth of shares (20,559 units at $3.84), increasing direct ownership by 24% to 243,392 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 109d
  Chief Financial Officer Kelly John Alexander converted options into 27,584 shares and sold $31,292 worth of shares (8,149 units at $3.84), increasing direct ownership by 18% to 125,883 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 109d
  General Counsel and Secretary Scimeca Dario converted options into 16,667 shares and sold $18,912 worth of shares (4,925 units at $3.84), increasing direct ownership by 26% to 56,457 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 109d
  Chief Research Officer Smith J. Jefferson converted options into 16,667 shares and sold $18,912 worth of shares (4,925 units at $3.84), increasing direct ownership by 11% to 121,926 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 137d
  President and CEO Amoroso Michael converted options into 115,378 shares and sold $145,112 worth of shares (34,799 units at $4.17), increasing direct ownership by 70% to 196,154 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 137d
  General Counsel and Secretary Scimeca Dario converted options into 25,311 shares and sold $35,682 worth of shares (8,854 units at $4.03), increasing direct ownership by 58% to 44,715 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 137d
  Chief Financial Officer Kelly John Alexander converted options into 44,363 shares and sold $61,308 worth of shares (15,213 units at $4.03), increasing direct ownership by 38% to 106,448 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 137d
  Chief Research Officer Smith J. Jefferson converted options into 29,166 shares and sold $41,106 worth of shares (10,200 units at $4.03), increasing direct ownership by 21% to 110,184 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 216d
  Chief Financial Officer Kelly John Alexander converted options into 3,605 shares and sold $8,456 worth of shares (1,303 units at $6.49), increasing direct ownership by 3% to 77,298 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 216d
  General Counsel and Secretary Scimeca Dario converted options into 1,835 shares and sold $4,316 worth of shares (665 units at $6.49), increasing direct ownership by 4% to 28,258 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 216d
  President and CEO Amoroso Michael converted options into 9,444 shares and sold $22,124 worth of shares (3,409 units at $6.49), increasing direct ownership by 6% to 115,575 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 335d
  Chief Financial Officer Kelly John Alexander sold $63,163 worth of shares (14,827 units at $4.26), decreasing direct ownership by 17% to 73,485 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 369d
  Director Germano Geno J converted options into 9,826 shares, increasing direct ownership by 89% to 20,883 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 369d
  Director Pire Shari Lisa converted options into 9,826 shares, increasing direct ownership by 234% to 14,028 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 369d
  Director Buehler Kevin converted options into 9,826 shares, increasing direct ownership by 74% to 23,061 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 369d
  Director Frankel Stanley converted options into 9,826 shares, increasing direct ownership by 231% to 14,078 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 369d
  SEC Form 4 filed by Chief Research Officer Smith J. Jefferson

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 369d
  Director Brown Melinda converted options into 9,826 shares, increasing direct ownership by 108% to 18,883 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 369d
  SEC Form 4 filed by President and CEO Amoroso Michael

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 369d
  SEC Form 4 filed by Chief Financial Officer Kelly John Alexander

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 369d
  SEC Form 4 filed by General Counsel and Secretary Scimeca Dario

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 440d
  President and CEO Amoroso Michael sold $5,360 worth of shares (964 units at $5.56) and converted options into 3,417 shares, increasing direct ownership by 2% to 109,540 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 460d
  Chief Research Officer Smith J. Jefferson converted options into 519 shares and sold $756 worth of shares (154 units at $4.91), increasing direct ownership by 0.42% to 87,805 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 460d
  General Counsel and Secretary Scimeca Dario converted options into 919 shares and sold $1,336 worth of shares (272 units at $4.91), increasing direct ownership by 3% to 25,000 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 460d
  Chief Financial Officer Kelly John Alexander converted options into 1,702 shares, increasing direct ownership by 2% to 86,256 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 502d
  General Counsel and Secretary Scimeca Dario converted options into 25,312 shares and sold $42,765 worth of shares (8,928 units at $4.79), increasing direct ownership by 206% to 24,353 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 502d
  President and CEO Amoroso Michael converted options into 115,388 shares and sold $172,033 worth of shares (36,838 units at $4.67), increasing direct ownership by 275% to 107,087 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 502d
  Chief Research Officer Smith J. Jefferson converted options into 29,168 shares and sold $49,275 worth of shares (10,287 units at $4.79), increasing direct ownership by 28% to 87,440 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 502d
  Chief Financial Officer Kelly John Alexander converted options into 44,368 shares, increasing direct ownership by 110% to 84,554 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 580d
  Chief Financial Officer Kelly John Alexander converted options into 3,605 shares, increasing direct ownership by 11% to 35,073 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 580d
  General Counsel and Secretary Scimeca Dario converted options into 1,836 shares and sold $4,816 worth of shares (588 units at $8.19), increasing direct ownership by 19% to 7,969 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 580d
  President and CEO Amoroso Michael converted options into 9,443 shares and sold $24,668 worth of shares (3,012 units at $8.19), increasing direct ownership by 29% to 28,537 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 655d
  SEC Form 4 filed by General Counsel and Secretary Scimeca Dario

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 655d
  SEC Form 4 filed by Chief Financial Officer Kelly John Alexander

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 655d
  SEC Form 4 filed by President and CEO Amoroso Michael

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 655d
  SEC Form 4 filed by Chief Research Officer Smith J. Jefferson

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 727d
  General Counsel and Secretary Scimeca Dario sold $1,096 worth of shares (93 units at $11.79) and converted options into 301 shares, increasing direct ownership by 3% to 6,721 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 727d
  Chief Financial Officer Kelly John Alexander converted options into 454 shares, increasing direct ownership by 1% to 31,468 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 727d
  Chief Research Officer Smith J. Jefferson converted options into 163 shares and sold $590 worth of shares (50 units at $11.79), increasing direct ownership by 0.17% to 68,559 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 732d
  SEC Form 4 filed by Brown Melinda

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 732d
  SEC Form 4 filed by Buehler Kevin

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 732d
  SEC Form 4 filed by Frankel Stanley

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 732d
  SEC Form 4 filed by Germano Geno J

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 732d
  SEC Form 4 filed by Pire Shari Lisa

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 732d
  SEC Form 4 filed by Wadsworth Samuel C.

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 761d
  Amoroso Michael was granted 8,334 shares, increasing direct ownership by 61% to 22,106 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)

Other DTIL categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends